ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >BN-2629

BN-2629

BN-2629 Suppliers list
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel:
Email: sales@boylechem.com
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Tel: 021-50182298 021-50180596
Email: sales@boylechem.com
Company Name: Artis Chemistry (Shanghai) Co. Ltd.  
Tel: 86-21-60936353
Email:
Company Name: Haoyuan Chemexpress Co., Ltd.  
Tel: 021-58950125
Email: info@chemexpress.com
Company Name: Shanghai Witofly Chemical Co.,Ltd  
Tel:
Email: sales@witofly.com

BN-2629 manufacturers

  • BN-2629
  • BN-2629 pictures
  • 2026-07-29
  • CAS:232931-57-6
  • Min. Order: 1KG
  • Purity: 98%
  • Supply Ability: 1000kg
  • SJG-136
  • SJG-136 pictures
  • $1820.00
  • 2026-06-15
  • CAS:232931-57-6
  • Purity:
  • Supply Ability: 10g
BN-2629 Basic information
Product Name:BN-2629
Synonyms:BN-2629;NSC 694501;SJG 136;UP 2001;SP-2001;(11aS,11'aS)-8,8'-[1,3-Propanediylbis(oxy)]bis[1,2,3,11a-tetrahydro-7-methoxy-2-methylene-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one;CS-1384;5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one, 8,8'-[1,3-propanediylbis(oxy)]bis[1,2,3,11a-tetrahydro-7-methoxy-2-methylene-, (11aS,11'aS)-
CAS:232931-57-6
MF:C31H32N4O6
MW:556.61
EINECS:
Product Categories:
Mol File:232931-57-6.mol
BN-2629 Structure
BN-2629 Chemical Properties
Boiling point 805.5±65.0 °C(Predicted)
density 1.36±0.1 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
solubility DMSO: ≥ 100 mg/mL (179.66 mM)
pka3.88±0.20(Predicted)
form Solid
color Off-white to yellow
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
BN-2629 Usage And Synthesis
UsesSJG-136 is a DNA cross-linking agent, with an XL50 of 45 nM for pBR322 DNA. SJG-136 has potent antitumor activity.
Biological ActivityHighly potent DNA cross-linking agent th at binds in the minor groove of DNA.

SJG-136 is a highly potent DNA cross-linking agent th at binds in the minor groove of DNA. SJG-136 exhibits potent anticancer activity in numerous cancer cell lines and in vivo. It exhibits significant inhibitory effect against Src activity.
Synthesis
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 8,8'-[1,3-propanediylbis(oxy)]bis[2,3-dihydro-7-methoxy-2-methylene-10-[[2-(trimethylsilyl)ethoxy]methyl]-, (11aS,11'aS)-

1221969-15-8

BN-2629

232931-57-6

The general procedure for the synthesis of (11aS,11a'S)-8,8'-(propane-1,3-diylbis(oxy))bis(7-methoxy-2-methylene-2,3-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5(11aH)-one) from the compound (CAS:1221969-15-8) was carried out as follows: the solid bis -SEM-dilactam 8 (100 mg, 0.12 mmol) was dissolved in a solvent mixture of ethanol (3 mL) and THF (3 mL). Lithium borohydride (22 mg, 2.3 mmol) was added all at once and the reaction mixture was stirred for 1 h under nitrogen protection. The completion of the reaction was monitored by LC/MS. The reaction mixture was partitioned between water (35 mL) and chloroform (50 mL). The organic phase was washed sequentially with water (35 mL), brine (35 mL), dried over magnesium sulfate and concentrated by rotary evaporation under reduced pressure. The residue was redissolved in a solvent mixture of chloroform (2 mL), ethanol (2 mL) and water (2.5 mL). Silica gel (4 g) was added and the mixture was stirred for 48 hours. The reaction mixture was filtered through a sintered funnel and washed with a solvent mixture of chloroform/methanol (90:10 v/v). The filtrate was extracted with chloroform, washed with brine, dried over magnesium sulfate and concentrated by rotary evaporation under reduced pressure. The residue was purified by fast chromatography (gradient elution: 100% CHCl3 to 97:3 v/v CHCl3/MeOH). The pure grades were collected and the solvent was removed by rotary evaporation under reduced pressure to give the target product SJG-136 as a mixture of imine and methanolamine methyl ether (46 mg, 70% yield). Analytical data: LC/MS 2.50 min (ES-) m/z (relative intensity) 555.06 ([M-H]-, 100); the analytical description is in agreement with the results previously published by Gregson et al. (J. Med. Chem. 2001, 44, 1161-1174). However, the observed [α]20D value was higher than the value reported in the literature: [α]20D = +766° (c = 0.37, HPLC CHCl3) (literature value [α]20D = +358° (c = 0.07, CHCl3)). This discrepancy is within expectations, as spin measurements are extremely sensitive to chloroform purity and the ratio of imine/carbamide adducts.

in vivo

SJG-136 shows more potent antitumor effect against CMeC-1 tumour at 0.30 mg/kg than 0.15 mg/kg either as a single dose or administered once a week for three weeks via dosed intravenously in mice. SJG-136-induced H2AX phosphorylation shows good correspondence, but less sensitivity, than measurement of foci[2].

IC 50Pyrrolobenzodiazepines
References[1] Gregson SJ, et al. Design, synthesis, and evaluation of a novel pyrrolobenzodiazepine DNA-interactive agent with highly efficient cross-linking ability and potent cytotoxicity. J Med Chem. 2001 Mar 1;44(5):737-48. DOI:10.1021/jm001064n
[2] Mellinas-Gomez M, et al. Activity of the DNA minor groove cross-linking agent SG2000 (SJG-136) against canine tumours. BMC Vet Res. 2015 Aug 19;11:215. DOI:10.1186/s12917-015-0534-2
Tag:BN-2629(232931-57-6) Related Product Information
SGD 1882 (11aS)-7-Methoxy-8-hydroxy-2,3,5,11aβ-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one, 1,2,3,11a-tetrahydro-7-methoxy-8-(phenylmethoxy)-, (11aS)- SG2057 SG3199 5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one, 8,8'-[1,5-pentanediylbis(oxy)]bis[1,2,3,11a-tetrahydro-7-methoxy-, (11aS,11'aS)-